DCAF7 and neoplasm: Collectively, these multi‐platform data indicate that DCAF7 shapes the immune milieu by influencing lymphocyte subsets, checkpoint‐gene expression and genomic‐instability metrics, thereby positioning it as a potential modulator of anti‐tumour immunity across cancers.